Pateclizumab

DB14997InvestigationalProtein Based Therapies

Pateclizumab is under investigation in clinical trial NCT01225393 (A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in...

Mechanism: Pharmacologically active on Lymphotoxin-alpha
Curator reviewed
Also known as: MLTA3698A

Resolves to

Compound

UNIIQOK1YYH7J2CAS1202526-59-7

Targets

P01374LTA

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

382Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pateclizumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account